Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence

被引:66
作者
Cooper, Ziva D.
Haney, Margaret [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Div Substance Abuse, New York, NY 10032 USA
关键词
CONDITIONED PLACE PREFERENCE; MESOLIMBIC DOPAMINE TRANSMISSION; MARIJUANA WITHDRAWAL SYNDROME; CB1 RECEPTOR AGONIST; SMOKED MARIJUANA; ORAL THC; ABSTINENCE SYMPTOMS; DELTA(9)-TETRAHYDROCANNABINOL THC; SEEKING BEHAVIOR; SUBSTANCE USE;
D O I
10.1080/09540260902782752
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Cannabis use disorders have been recently identified as a relevant clinical issue: a subset of cannabis smokers seeks treatment for their cannabis use, yet few succeed in maintaining long-term abstinence. The rewarding and positive reinforcing effects of the primary psychoactive component of smoked cannabis, delta-9-tetrahydrocannabinol (THC) are mediated by the cannabinoid CB1 receptor. The CB1 receptor has also been shown to mediate cannabinoid dependence and expression of withdrawal upon cessation of drug administration, a phenomenon verified across species. This paper will review findings implicating the CB1 receptor in the behavioural effects of exogenous cannabinoids with a focus on cannabinoid dependence and reinforcement, factors that contribute to the maintenance of chronic cannabis smoking despite negative consequences. Opioidergic modulation of these effects is also discussed.
引用
收藏
页码:104 / 112
页数:9
相关论文
共 102 条
[41]   MORPHINE AND DELTA-9-TETRAHYDROCANNABINOL - TOLERANCE TO STIMULUS EFFECTS [J].
HIRSCHHORN, ID ;
ROSECRANS, JA .
PSYCHOPHARMACOLOGIA, 1974, 36 (03) :243-253
[42]   Blockade of effects of smoked marijuana by the CBl-selective cannabinoid receptor antagonist SR141716 [J].
Huestis, MA ;
Gorelick, DA ;
Heishman, SJ ;
Preston, KL ;
Nelson, RA ;
Moolchan, ET ;
Frank, RA .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (04) :322-328
[43]   Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users [J].
Huestis, Marilyn A. ;
Boyd, Susan J. ;
Heishman, Stephen J. ;
Preston, Kenzie L. ;
Bonnet, Denis ;
Le Fur, Gerard ;
Gorelick, David A. .
PSYCHOPHARMACOLOGY, 2007, 194 (04) :505-515
[44]   Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ-9-tetrahydrocannabinol [J].
Hutcheson, DM ;
Tzavara, ET ;
Smadja, C ;
Valjent, E ;
Roques, BP ;
Hanoune, J ;
Maldonado, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (07) :1567-1577
[45]  
Järbe TUC, 2001, PSYCHOPHARMACOLOGY, V156, P369
[46]   Antagonism of discriminative stimulus effects of Δ9-THC and (R)-methanandamide in rats [J].
Järbe, TUC ;
Liu, QA ;
Makriyannis, A .
PSYCHOPHARMACOLOGY, 2006, 184 (01) :36-45
[47]   CLINICAL STUDIES OF CANNABIS TOLERANCE AND DEPENDENCE [J].
JONES, RT ;
BENOWITZ, N ;
BACHMAN, J .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 282 (DEC30) :221-239
[48]   CLINICAL RELEVANCE OF CANNABIS TOLERANCE AND DEPENDENCE [J].
JONES, RT ;
BENOWITZ, NL ;
HERNING, RI .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S143-S152
[49]   The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys [J].
Justinova, Z ;
Tanda, G ;
Munzar, P ;
Goldberg, SR .
PSYCHOPHARMACOLOGY, 2004, 173 (1-2) :186-194
[50]   Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys [J].
Justinova, Z ;
Tanda, G ;
Redhi, GH ;
Goldberg, SR .
PSYCHOPHARMACOLOGY, 2003, 169 (02) :135-140